4//SEC Filing
Dash Barry H 4
Accession 0001144204-09-035918
CIK 0001053369other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:10 AM ET
Size
10.9 KB
Accession
0001144204-09-035918
Insider Transaction Report
Form 4
Dash Barry H
Director
Transactions
- Conversion
Common Stock
2009-06-03$1.61/sh+12,243$19,711→ 35,932 total - Conversion
Series C 8% Convertible Preferred Stock
2009-06-03$1000.00/sh−20$20,000→ 0 totalExercise: $1.61From: 2007-04-24→ Common Stock (12,243 underlying) - Other
Common Stock Warrant
2009-06-03+12,243→ 14,829 totalExercise: $0.25From: 2009-06-03Exp: 2014-06-03→ Common Stock (12,243 underlying)
Footnotes (4)
- [F1]The Registrant's Series C 8% Convertible Preferred Stock, par value $0.01 per share (the "Series C Preferred Stock"), is convertible into the Registrant's common stock, par value $0.01 per share (the "Common Stock"), at a conversion price per share of $1.61, as adjusted. On June 3, 2009, the Reporting Person converted 20 shares of Series C Preferred Stock resulting in the issuance to the Reporting Person of 12,243 shares of Common Stock.
- [F2]Represents 12,243 shares of Common Stock issued to the Reporting Person upon the conversion on June 3, 2009 of 20 shares of Series C Preferred Stock; 16,689 shares of Common Stock issued to the Reporting Person in satisfaction of dividend obligations on the 20 shares of Series C Preferred Stock held by the Reporting Person from April 24, 2007 to June 3, 2009; and 7,000 shares of Common Stock previously purchased by the Reporting Person.
- [F3]The Series C Preferred Stock shall remain outstanding until converted to Common Stock by the holder or the Registrant pursuant to the terms thereof.
- [F4]The Warrant was issued pursuant to the Conversion Agreement between the Registrant and the Reporting Person, dated as of April 22, 2009, in consideration of the Reporting Person's agreement to convert all shares of the Registrant's preferred stock held by the Reporting Person into Common Stock on or before the initial closing of the transactions contemplated by that certain Strategic Alliance Agreement, dated as of March 18, 2009, by and among the Registrant, on the one hand, and Epic Pharma, LLC and Epic Investments, LLC, on the other hand. The Warrant is exercisable for up to 12,243 shares of Common Stock at an exercise price per share of $0.25. The number of shares issuable upon exercise of the Warrant, and the exercise price per share thereof, is subject to adjustment pursuant to the terms of the Warrant.
Documents
Issuer
ELITE PHARMACEUTICALS INC /DE/
CIK 0001053369
Entity typeother
Related Parties
1- filerCIK 0001324222
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 6:10 AM ET
- Size
- 10.9 KB